Internal Medicine · Sacramento, CA
NPI
1760634778
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
6830 Stockton Blvd Ste 155
Sacramento, CA, 95823
Phone (916) 476-3008
Groups this clinician bills Medicare through
Medicare paid, 2024
$152K
2,158 services
Medicare patients, 2024
425
Average age 74
Drug cost, 2024
$3.1M
26,683 prescriptions
Company payments, 2025
$490
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin A Vu was code 99213 (office e&m - established), 1,268 times for 388 patients. In total Kevin A Vu billed 2,158 services in 13 codes, and Medicare paid $152K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,268 | 388 | $55.97 | $71K |
| 99497 Care Management/Coordination | Office | 305 | 287 | $72.14 | $22K |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 158 | 158 | $172.80 | $27K |
| 99203 Office E&M - New | Office | 121 | 121 | $56.04 | $6,781 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 102 | 102 | $20.45 | $2,086 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 93 | 93 | $134.75 | $13K |
| 99214 Office E&M - Established | Office | 54 | 50 | $84.47 | $4,561 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 28 | 28 | $173.44 | $4,856 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 15 | 15 | $20.56 | $308 |
By year: 2022 $36K for 751 services; 2023 $106K for 1,502 services; 2024 $152K for 2,158 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin A Vu prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,874 prescriptions and refills. In total Kevin A Vu wrote 26,683 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,874 | 5,071 | 552 | $14K |
| Losartan Potassium Generic | 1,137 | 3,014 | 332 | $5,487 |
| Jardiance Empagliflozin | 1,089 | 1,553 | 228 | $880K |
| Amlodipine Besylate Generic | 937 | 2,609 | 303 | $2,908 |
| Metformin Hcl Generic | 934 | 2,445 | 257 | $4,347 |
| Triamcinolone Acetonide Generic | 787 | 917 | 239 | $4,727 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 753 | 822 | 189 | $25K |
| Azelastine Hcl Generic | 704 | 848 | 182 | $6,421 |
| Gabapentin Generic | 687 | 1,720 | 228 | $6,819 |
| Lisinopril Generic | 593 | 1,517 | 177 | $1,885 |
| Fluticasone Propionate Generic | 553 | 704 | 162 | $4,965 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 502 | 1,426 | 171 | $5,228 |
| Omeprazole Generic | 498 | 1,361 | 191 | $3,691 |
| Rosuvastatin Calcium Generic | 482 | 1,327 | 149 | $4,779 |
| Meloxicam Generic | 450 | 1,180 | 167 | $1,677 |
Brand drugs: 4,561 claims; generic drugs: 21,821 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin A Vu $490 ($490 in general payments such as food, travel and fees) from 9 companies. The largest payer was Gilead Sciences, Inc. with $211.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 10 | $211 |
| Abbvie Inc. ABBV | 3 | $64.3 |
| Cordis US Corp. JNJ | 2 | $41.08 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $40.47 |
| Boston Scientific Corporation BSX | 1 | $33.28 |
| Novo Nordisk Inc NVO | 1 | $28.74 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $26.92 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $22.33 |
| Exact Sciences Corporation EXAS | 1 | $21.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.